Patients may experience acute and subacute symptoms following administration that commonly include nausea, fatigue, and localized discomfort. Nausea often occurs within hours to a day and can be transient; fatigue can begin during the first week and persist for varying durations. Some individuals report temporary increases in pain at sites of known disease, sometimes described as a pain flare. Symptom onset and severity typically vary by individual and by the specifics of the treatment protocol.

Management of acute symptoms in clinical settings commonly relies on established supportive-care approaches used for other systemic therapies. Antiemetics, short-term analgesics, and adjustments in daily activity are described in practice documents as potential components of symptom control, subject to clinician evaluation. Caregivers frequently assist patients in tracking the timing, intensity, and triggers of symptoms so the health team can tailor recommendations during follow-up contacts.
Hydration, rest, and gradual return to activity are often advised as general supportive measures when fatigue or mild gastrointestinal symptoms occur; such advice is usually individualized by clinicians. Nutrition changes, small frequent meals, and attention to fluid balance may help alleviate mild nausea. Documentation of symptom patterns across treatment cycles helps clinicians assess tolerability and consider whether additional supportive resources are needed for subsequent administrations.
When symptoms are more pronounced or persistent, clinicians may evaluate other causes such as infection, medication interactions, or disease progression. Caregivers can facilitate timely assessment by reporting red-flag signs such as high fever, severe or uncontrolled pain, bleeding, or signs of dehydration. These observational roles contribute to safe monitoring and appropriate escalation when clinically indicated.